Full Press Release Details
THOUSAND OAKS, Calif. , Sept. 15, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will participate in the UBS Global Life Sciences Conference on Tuesday, Sept. 20, 2011 , at the Grand Hyatt in New York City , beginning at 8:30 a.m. Eastern Time . Roger M. Perlmutter, M.D., Ph.D., executive vice president of Research and Development at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com , under Investors.
CONTACT: Amgen, Thousand Oaks Christine Regan , 805-447-5476 (media) Arvind Sood , 805-447-1060 (investors)